Everest Organics Limited Developed Molnupiravir, A New API to Treat COVID-I9
Everest Organics Limited today announced the successful development of an anti-viral API ‘MOLNUPIRAVIR’ an additional COVID-19 treatment drug that is being developed at Lab Scale for the first-line treatment of COVID-19 in adults patients with mild to moderate symptoms.